Chemotherapy & More
- This forum has 1,151 topics, 3,414 replies, and was last updated 2 years ago by
.
-
- Topic
- Voices
- Posts
- Last Post
-
- Predicting prognosis and evaluating the benefits of adjuvant chemotherapy depend
- 1
- 1
- 2 years, 6 months ago
- Vemurafenib effectively controlled Chemotherapy-refractory Intrahepatic Cholangi
- 1
- 1
- 2 years, 6 months ago
- Recent Trends and In-Hospital Mortality of Transarterial Chemoembolization (TACE
- 1
- 1
- 2 years, 6 months ago
- Is it safe to administer neoadjuvant chemotherapy to patients undergoing hepatec
- 1
- 1
- 2 years, 7 months ago
- Lapatinib Suppresses HER2-Overexpressed Cholangiocarcinoma and Overcomes ABCB1-
- 1
- 1
- 2 years, 7 months ago
- Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangioc
- 1
- 1
- 2 years, 7 months ago
- Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine,
- 1
- 1
- 2 years, 7 months ago
- Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances
- 1
- 1
- 2 years, 7 months ago
- Intrahepatic Cholangiocarcinoma With Neither Intrahepatic Metastasis Nor Lymph N
- 1
- 1
- 2 years, 7 months ago
- Robust Response to Futibatinib in a Patient With Metastatic FGFR-Addicted Cholan
- 1
- 1
- 2 years, 7 months ago
- Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP S
- 2
- 2
- 2 years, 7 months ago
- FDA Approval Summary: Ivosidenib for the treatment of patients with advanced unr
- 3
- 3
- 2 years, 8 months ago
- Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Car
- 1
- 1
- 2 years, 8 months ago
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.